Sam Brusco, Associate Editor08.28.23
Philips researchers presented data at the European Society of Cardiology Congress showing how specific diagnostic referral codes could help predetermine how long a cardiology patient should receive Holter monitoring to monitor symptoms remotely, possible preventing further hospitalization.
Holter monitor electrocardiography (ECG) helps spot potential arrhythmias like AFib in patients exhibiting chest pain, shortness of breath, or palpitation. Extended-wear Holter (EWH) monitors like Philips ePatch are worn for several days of continuous monitoring. While they’ve become more common in U.S. clinical practice, Philips said they’re still far from the standard internationally.
Researchers from Philips compared one, seven, and 14 days of retrospective data collected from Philips ePatch EWH monitor. Results showed extending ePatch monitoring caused twice the number of clinically actionable findings after seven days and over2.5 times the findings after 14 days. With such strong initial findings, the team decided to continue their deep dive analysis to loomore closely examine specific diagnoses to better understand the impact of using extended monitoring.
When ordering Holter monitoring, clinicians must provide a referral diagnosis to indicate the reason for the study. Researchers once again compared retrospective ePatch data to determine the impact of referral diagnosis on overall diagnostic yield for clinically significant arrhythmias using ePatch for one, seven, and 14 days (figure 1).
Data was analyzed from over 40,000 ePatch patients, and found three tiers of referall diagnoses based on one-day monitoring results.
The results showed referral diagnosis can potentially guide prescribed monitoring duration. Philips’ poster presentation can be viewed here.
Philips acquired ePatch from BioTelemetry in December 2020.
Holter monitor electrocardiography (ECG) helps spot potential arrhythmias like AFib in patients exhibiting chest pain, shortness of breath, or palpitation. Extended-wear Holter (EWH) monitors like Philips ePatch are worn for several days of continuous monitoring. While they’ve become more common in U.S. clinical practice, Philips said they’re still far from the standard internationally.
Researchers from Philips compared one, seven, and 14 days of retrospective data collected from Philips ePatch EWH monitor. Results showed extending ePatch monitoring caused twice the number of clinically actionable findings after seven days and over2.5 times the findings after 14 days. With such strong initial findings, the team decided to continue their deep dive analysis to loomore closely examine specific diagnoses to better understand the impact of using extended monitoring.
When ordering Holter monitoring, clinicians must provide a referral diagnosis to indicate the reason for the study. Researchers once again compared retrospective ePatch data to determine the impact of referral diagnosis on overall diagnostic yield for clinically significant arrhythmias using ePatch for one, seven, and 14 days (figure 1).
Data was analyzed from over 40,000 ePatch patients, and found three tiers of referall diagnoses based on one-day monitoring results.
- Tier 1: The five referral codes with the lowest diagnostic yield, or detection, at day 1 [figure 2] had the most increase with extended monitoring, suggesting these patients would benefit most from extended monitoring duration.
- Tier 2: Referral diagnoses with a 20-30% detection at day 1 [figure 2] matched previous overall diagnostic detection findings with increases continuing to day 14 of monitoring.
- Tier 3: The four referral diagnoses with the highest detection at day 1 [figure 2] had “significant increases” in diagnostic yield at day 7 that continued to increase at day 14, but not quite as dramatically as the Tier 1 referrals.
The results showed referral diagnosis can potentially guide prescribed monitoring duration. Philips’ poster presentation can be viewed here.
Philips acquired ePatch from BioTelemetry in December 2020.